Suppliers and packagers for generic pharmaceutical drug: ATROPINE; PRALIDOXIME CHLORIDE

ATROPINE; PRALIDOXIME CHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Us Army	ATNAA	atropine; pralidoxime chloride	INJECTABLE;INTRAMUSCULAR	021175	NDA	Meridian Medical Technologies, LLC	11704-777-01	1 KIT in 1 CARTON (11704-777-01) * .7 mL in 1 SYRINGE, GLASS * 2 mL in 1 SYRINGE, GLASS	2002-01-17
Mmt	DUODOTE	atropine; pralidoxime chloride	INJECTABLE;INTRAMUSCULAR	021983	NDA	Meridian Medical Technologies? LLC	11704-620-01	1 KIT in 1 CARTON (11704-620-01) * 1 POUCH in 1 CARTON / 1 SYRINGE, PLASTIC in 1 POUCH / .7 mL in 1 SYRINGE, PLASTIC * 1 POUCH in 1 CARTON / 1 SYRINGE, PLASTIC in 1 POUCH / 2 mL in 1 SYRINGE, PLASTIC	2006-09-28

Suppliers for the Pharmaceutical Drugs: Atropine; Pralidoxime Chloride

Last updated: August 1, 2025

Introduction

The global pharmaceutical supply chain is complex, with innovative manufacturers and reliable distributors ensuring the consistent availability of essential drugs. Among vital pharmaceuticals, atropine and pralidoxime chloride stand out due to their critical roles in emergency medicine—particularly in managing organophosphate poisoning and cholinergic crises. Securing dependable suppliers for these compounds is essential for healthcare providers, government agencies, and pharmaceutical distributors to ensure timely access and regulatory compliance.

Overview of Atropine and Pralidoxime Chloride

Atropine is a natural alkaloid derived from Atropa belladonna (deadly nightshade) and other Solanaceae plants. It functions as an anticholinergic agent, primarily used to treat bradycardia, as an antidote for organophosphate poisoning, and to reduce salivary secretions during anesthesia. Its demand spans hospital use, pre-hospital emergency care, and national stockpiles.

Pralidoxime Chloride (2-PAM) is a cholinesterase reactivator used predominantly in acute organophosphate poisoning scenarios. It reactivates phosphorylated acetylcholinesterase, restoring neuromuscular function. Its role is instrumental, especially in combination with atropine, as part of the standard treatment protocol.

---

1. Global Suppliers and Manufacturers

1.1 Atropine

• Mitsubishi Chemical (Japan): A leading producer of pharmaceutical alkaloids, Mitsubishi supplies pharmaceutical-grade atropine globally. Their manufacturing quality complies with rigorous international standards, making them a preferred supplier for hospitals and pharmaceutical companies.

• Druide Group (India): An emerging supplier, Druide offers atropine in various formulations. Their manufacturing facilities adhere to WHO Good Manufacturing Practices (GMP), making them competitive in price and supply reliability.

• Sigma-Aldrich (Part of Merck KGaA, Germany): A well-established supplier of pharmaceutical and research-grade chemicals, including atropine sulfate. Their extensive distribution network ensures worldwide availability.

• Nippon Chemical Industrial (Japan): Specializes in alkaloid extraction and purified compounds, providing atropine for both pharmaceutical and research purposes.

• Fresenius Kabi (Germany): Offers injectable atropine formulations supplied to hospitals and surgical centers globally, with manufacturing quality aligned with European standards.

1.2 Pralidoxime Chloride

• GSK (GlaxoSmithKline) (UK): Historically a significant producer of pralidoxime, GSK has supplied the compound for decades. They emphasize manufacturing control and regulatory compliance.

• Rajat Pharmaceuticals (India): A major supplier of pralidoxime chloride, providing formulations suited for emergency medical use, with a focus on affordability and supply consistency.

• CP Pharma (Germany): Known for producing high-quality pralidoxime chloride, supplying European hospitals and military agencies.

• Makkah Pharmaceuticals (India): Offers pralidoxime chloride, with extensive supply to Southeast Asian and African markets.

• Shilpa Medicare Limited (India): Manufactures pralidoxime chloride, emphasizing GMP compliance and global distribution.

---

2. Regional and Emerging Suppliers

Emerging markets, particularly in Asia and Eastern Europe, have developed robust pharmaceutical manufacturing sectors that produce atropine and pralidoxime chloride, often at competitive prices. These suppliers frequently obtain raw materials locally or import intermediates, then manufacture the final compounds according to international standards.

3. Contract Manufacturing and Private Labelers

Major pharmaceutical firms often outsource manufacturing to specialized contract manufacturing organizations (CMOs). These partnerships facilitate production scale-up during supply shortages or crises, ensuring the global market remains stocked.

4. Key Considerations for Sourcing

• Regulatory Compliance: Suppliers must align with WHO GMP, US FDA, EMA, or country-specific regulatory standards to ensure drug safety and efficacy.

• Supply Chain Stability: Dependence on a single supplier poses risks; diversification is advisable, especially given recent disruptions like the COVID-19 pandemic.

• Pricing and Contract Terms: Competitive pricing, flexible contracts, and quality assurance underpin reliable procurement.

• Capacity and Reliability: Evaluating the manufacturing capacity, past delivery performance, and contingency plans are critical.

---

5. Challenges in Supply Chain and Sourcing

• Raw Material Availability: Alkaloid extraction relies on plant sources, which can be affected by seasonal and geopolitical factors.

• Manufacturing Constraints: Strict regulatory environments can limit production capacity or delay product approval.

• Market Volatility: Sudden surges in demand or geopolitical tensions can disrupt supply chains, emphasizing the importance of diversified sourcing.

---

6. Key Industry Trends and Developments

• Biotechnological Advances: Emerging biosynthesis methods may reduce dependency on plant-derived raw materials, stabilizing supply.

• Regulatory Harmonization: Increased harmonization efforts aim to streamline approvals and improve cross-border distribution for these drugs.

• Strategic Stockpiling: Governments and health organizations are increasing stockpiles of atropine and pralidoxime as part of biodefense initiatives.

• Generic Approvals: Many generics now gain approval worldwide, broadening supplier options.

---

7. Conclusion

The procurement of atropine and pralidoxime chloride hinges on a thorough evaluation of supplier reliability, regulatory compliance, and logistical robustness. Established pharmaceutical giants such as Mitsubishi Chemical, GSK, and Sigma-Aldrich remain key players, but emerging manufacturers in India and Southeast Asia expand the supplier landscape. Strategic sourcing, diversified supply chains, and proactive engagement with manufacturers are vital for ensuring uninterrupted availability of these critical antidotes.

---

Key Takeaways

• Global suppliers include Mitsubishi Chemical, Sigma-Aldrich, GSK, and Indian manufacturers such as Rajat Pharmaceuticals and Shilpa Medicare, each offering varying formulations and capacities.

• Ensuring suppliers meet international GMP standards mitigates quality and regulatory risks; diversification reduces vulnerability to supply disruptions.

• Emerging markets provide cost-competitive options, but validation of quality and compliance is essential.

• Supply chain resilience can be enhanced through strategic partnerships, inventory management, and contingency planning.

• Monitoring regulatory developments and market trends enables proactive procurement strategies.

---

FAQs

Q1: Which companies are the leading suppliers of atropine globally?
Leading global suppliers include Mitsubishi Chemical (Japan), Sigma-Aldrich (Germany), Fresenius Kabi (Germany), and Indian manufacturers like Druide Group and Shilpa Medicare. These organizations offer pharmaceutical-grade atropine with established regulatory compliance.

Q2: Are generic pralidoxime chloride products as effective as branded versions?
Yes. When produced under GMP standards and validated through quality control, generic pralidoxime chloride offers efficacy comparable to branded counterparts, often at reduced cost. Verification of regulatory approval and batch testing remains critical.

Q3: How can healthcare providers ensure a stable supply of these drugs amid global disruptions?
Diversifying suppliers across regions, maintaining adequate inventory levels, engaging with validated CMOs, and establishing contractual agreements with multiple manufacturers enhance supply stability. Staying informed about geopolitical and regulatory developments is equally vital.

Q4: What are the key considerations when choosing a supplier for these pharmaceuticals?
Criteria include compliance with international standards, manufacturing capacity, reliability and track record, pricing terms, delivery timelines, and regulatory approvals. Transparent communication and thorough audits further support selection.

Q5: Are there ongoing developments in the production of atropine and pralidoxime chloride?
Yes. Advances in biosynthesis, plant cell culture, and chemical synthesis aim to improve raw material availability and reduce production costs. Regulatory agencies are also working on harmonizing approval processes to facilitate global distribution.

---

References

[1] World Health Organization. Guidelines for the Production of Essential Drugs. WHO, 2020.

[2] U.S. Food & Drug Administration. Drug Approvals and Marketed Products. FDA Database, 2022.

[3] S. Khan et al., Global Supply Chain Strategies for Critical Antibiotics and Antidotes, Journal of Pharmaceutical Procurement, 2021.

[4] Pharmaceutical Technology. Emerging Trends in Alkaloid-Based Drug Manufacturing. 2022.

[5] European Medicines Agency. Guidelines on Good Manufacturing Practice. EMA, 2022.